Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Organisation › Details

Creoptix Inc.

Creoptix is a private company headquartered in Wädenswil, near Zurich, Switzerland, and with US offices in the Boston area. Creoptix focuses on next-generation bioanalytical instruments for drug discovery and development as well as academic research. Based on its proprietary sensor and microfluidics technology, the Creoptix WAVE systems provide exceptionally high sensitivity and resolution in characterizing real-time interactions between small molecules, peptides, proteins and other molecules and even in crude samples like undiluted serum or plasma. *


Period Start 2017-02-06 existent
  Group Creoptix (Group)
  Today Creoptix (Group)
Products Industry Creoptix WAVE system
  Industry 2 waveguide interferometry technology
Region Region Burlington, MA
  Country United States (USA)
  Street 111 South Bedford Street
c/o The Brighton Company, Suite 108
  City 01803 Burlington, MA
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich).
Record changed: 2019-10-01


Picture EBD Group Global Partnering Four Events One Price 650x80

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Fighting Customers 650x80px

» top